Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03248206
Other study ID # A-ER-105-257
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date August 23, 2017
Est. completion date December 14, 2018

Study information

Verified date December 2018
Source National Cheng-Kung University Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

In this research work, the concept of strengthening technique of proprioceptive neuromuscular facilitation (PNF) incorporated with tendon gliding exercise (TGE) will be used to improve neuromuscular function of upper extremity of patients with diabetes mellitus. The first specific aim of the study is to examine the effects of home-based PNF exercise on the motor, sensation and functional performance parameters of upper extremity of the patients with diabetes mellitus. In addition, whether adding a tendon gliding exercise (TGE) to the home-based PNF exercises can provide better treatment effects for the patients with diabetes mellitus will also been investigated in this study. One of the hypothesis of this study is the prescribing home-based PNF exercise program has a positive treatment effect on neuromuscular function of the upper extremity of patients with diabetes mellitus. And,the other is home-based PNF in conjunction with TGE provides better benefits for neuromuscular function of the upper extremity of patients with diabetes mellitus.


Recruitment information / eligibility

Status Completed
Enrollment 12
Est. completion date December 14, 2018
Est. primary completion date August 14, 2018
Accepts healthy volunteers No
Gender All
Age group 20 Years to 80 Years
Eligibility Inclusion Criteria:

- Study participants will include clinically defined diabetic patients who are diagnosed based on the 1997 criteria of the American Diabetes Association. The inclusion criteria of the enrolled subjects are who suffered from neuropathy as diagnosed by abnormalities in either a nerve conduction study and / or quantitative sensory testing.

Exclusion Criteria:

- DM patients with (1) traumatic nerve injuries of the upper limbs, (2) trauma to the hand or congenital anomalies of the wrist and hand, (3) skin infections or disease, (4) known vascular complications of diabetes, such as stroke may have compromised the physical integrity of the patient, (5) grade 2 or higher arterial hypertension (>160/100 mmHg) or (6) cognitive deficits

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
lifestyle changes
Providing a home-based exercise program supervised by therapists can be an acceptable strategy with the characteristics of convenience and inexpensiveness to promote neuromuscular and functional component for the patients with diabetes mellitus.

Locations

Country Name City State
Taiwan National Cheng-Kung University Hospital Tainan

Sponsors (1)

Lead Sponsor Collaborator
National Cheng-Kung University Hospital

Country where clinical trial is conducted

Taiwan, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change from baseline result of Semmes-Weinstein monofilament (SWM) test at 12 weeks determine the touch-pressure threshold of the hands pre-intervention (week 0), post-intervention (week 12) and follow-up evaluation (week 24)
Primary Change from baseline result of Nerve conduction study (NCS) at 12 weeks determine nerve condition through detection of the amplitude of the sensory and motor nerve action potential pre-intervention (week 0) and follow-up evaluation (week 24)
Primary Change from baseline result of pinch-holding-up activity test at 12 weeks sensorimotor control of a hand pre-intervention (week 0), post-intervention (week 12) and follow-up evaluation (week 24)
Primary Change from baseline result of Purdue pegboard test at 12 weeks determine fine fingertip dexterity pre-intervention (week 0), post-intervention (week 12) and follow-up evaluation (week 24)
Primary Change from baseline result of Minnesota Manual Dexterity Test at 12 weeks determine unilateral and bilateral gross motor coordination of upper extremity pre-intervention (week 0), post-intervention (week 12) and follow-up evaluation (week 24)
Primary Change from baseline result of Manual tactile test at 12 weeks determine active touching sensation pre-intervention (week 0), post-intervention (week 12) and follow-up evaluation (week 24)
Secondary Change from baseline result of Grasp and pinch power at 12 weeks Grip strength of the hands will be assessed with a Jamar dynamometer pre-intervention (week 0), post-intervention (week 12) and follow-up evaluation (week 24)
Secondary Change from baseline result of pinch power at 12 weeks Pinch power is measured with a pinch gauge pre-intervention (week 0), post-intervention (week 12) and follow-up evaluation (week 24)
Secondary Change from baseline result of of shoulder flexion assessing by Micro FET hand-held dynamometer at 12 weeks Peak force of shoulder flexion (N) will be measured pre-intervention (week 0), post-intervention (week 12) and follow-up evaluation (week 24)
Secondary Change from baseline result of shoulder internal rotation assessing by Micro FET hand-held dynamometer at 12 weeks Peak force of shoulder internal rotation (N) will be measured pre-intervention (week 0), post-intervention (week 12) and follow-up evaluation (week 24)
Secondary Change from baseline result of shoulder external rotation assessing by Micro FET hand-held dynamometer at 12 weeks Peak force of shoulder external rotation (N) will be measured pre-intervention (week 0), post-intervention (week 12) and follow-up evaluation (week 24)
Secondary Change from baseline result of peak torque of shoulder external rotation assessing by Bi-planar isokinetic dynamometer (BID) at 12 weeks Peak torque of shoulder external rotation (N·m) will be obtained pre-intervention (week 0), post-intervention (week 12) and follow-up evaluation (week 24)
Secondary Change from baseline result of peak torque of shoulder internal rotation assessing by Bi-planar isokinetic dynamometer (BID) at 12 weeks Peak torque (PT) of shoulder internal rotation (N·m) will be obtained pre-intervention (week 0), post-intervention (week 12) and follow-up evaluation (week 24)
See also
  Status Clinical Trial Phase
Completed NCT03743779 - Mastering Diabetes Pilot Study
Completed NCT03786978 - Pharmaceutical Care in the Reduction of Readmission Rates in Diabetes Melitus N/A
Completed NCT01804803 - DIgital Assisted MONitoring for DiabeteS - I N/A
Completed NCT05039970 - A Real-World Study of a Mobile Device-based Serious Health Game on Session Attendance in the National Diabetes Prevention Program N/A
Completed NCT04507867 - Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III N/A
Completed NCT04068272 - Safety of Bosentan in Type II Diabetic Patients Phase 1
Completed NCT03243383 - Readmission Prevention Pilot Trial in Diabetes Patients N/A
Completed NCT03730480 - User Performance of the CONTOUR NEXT and CONTOUR TV3 Blood Glucose Monitoring System (BGMS) N/A
Recruiting NCT02690467 - Efficacy, Safety and Acceptability of the New Pen Needle 34gx3,5mm. N/A
Completed NCT02229383 - Phase III Study to Evaluate Safety and Efficacy of Added Exenatide Versus Placebo to Titrated Basal Insulin Glargine in Inadequately Controlled Patients With Type II Diabetes Mellitus Phase 3
Completed NCT06181721 - Evaluating Glucose Control Using a Next Generation Automated Insulin Delivery Algorithm in Patients With Type 1 and Type 2 Diabetes N/A
Completed NCT05799976 - Text Message-Based Nudges Prior to Primary Care Visits to Increase Care Gap Closure N/A
Recruiting NCT04489043 - Exercise, Prediabetes and Diabetes After Renal Transplantation. N/A
Withdrawn NCT03319784 - Analysis for NSAID VS Corticosteroid Shoulder Injection in Diabetic Patients Phase 4
Completed NCT03542084 - Endocrinology Auto-Triggered e-Consults N/A
Completed NCT02229396 - Phase 3 28-Week Study With 24-Week and 52-week Extension Phases to Evaluate Efficacy and Safety of Exenatide Once Weekly and Dapagliflozin Versus Exenatide and Dapagliflozin Matching Placebo Phase 3
Recruiting NCT05544266 - Rare and Atypical Diabetes Network
Completed NCT01892319 - An International Non-interventional Cohort Study to Evaluate the Safety of Treatment With Insulin Detemir in Pregnant Women With Diabetes Mellitus. Diabetes Pregnancy Registry
Completed NCT05031000 - Blood Glucose Monitoring Systems: Discounter Versus Brand N/A
Recruiting NCT04039763 - RT-CGM in Young Adults at Risk of DKA N/A